Mimedx (MDXG) Cash from Financing Activities (2011 - 2026)
Mimedx recorded quarterly Cash from Financing Activities of -$2.6 million in Q1 2026, down 343.4% quarter-over-quarter from -$583000.0 in Q4 2025, and up 10.18% year-over-year from -$2.3 million in Q1 2025.
Mimedx's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 10.18% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$5.1 million (down 41.8% YoY), while the FY2025 annual figure was -$5.4 million, up 84.17% from the prior year.
- Cash from Financing Activities came in at -$2.6 million for Q1 2026 at Mimedx, down from -$583000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $370000.0 in Q3 2023 to a low of -$33.5 million in Q1 2024.
- A 5-year average of -$3.0 million and a median of -$400000.0 in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities soared 200.0% in 2022 and slumped 836575.0% in 2024, its largest moves.
- Mimedx's Cash from Financing Activities stood at $66000.0 in 2022, then tumbled by 13645.45% to -$8.9 million in 2023, then soared by 95.53% to -$400000.0 in 2024, then slumped by 45.75% to -$583000.0 in 2025, then tumbled by 343.4% to -$2.6 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$2.6 million, -$583000.0, and -$857000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.59 Mn |
| Mar 31, 2026 | -2.59 Mn |
| Dec 31, 2025 | -583,000.00 |
| Dec 31, 2025 | -583,000.00 |
| Sep 30, 2025 | -857,000.00 |
| Sep 30, 2025 | -857,000.00 |
| Jun 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -2.88 Mn |
| Mar 31, 2025 | -2.88 Mn |
| Dec 31, 2024 | -400,000.00 |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | -359,000.00 |
| Jun 30, 2024 | -359,000.00 |
| Mar 31, 2024 | -33.47 Mn |
| Mar 31, 2024 | -33.47 Mn |
| Dec 31, 2023 | -8.94 Mn |
| Dec 31, 2023 | -8.94 Mn |
| Sep 30, 2023 | 370,000.00 |
| Sep 30, 2023 | 370,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 260,000.00 |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -150,000.00 |
| Sep 30, 2021 | -150,000.00 |
| Jun 30, 2021 | -916,000.00 |
| Jun 30, 2021 | -916,000.00 |
| Mar 31, 2021 | -2.31 Mn |
| Mar 31, 2021 | -2.31 Mn |
| Dec 31, 2020 | -1.24 Mn |
| Dec 31, 2020 | -1.24 Mn |
| Sep 30, 2020 | 66.73 Mn |
| Sep 30, 2020 | 66.73 Mn |
| Jun 30, 2020 | -1.75 Mn |
| Jun 30, 2020 | -1.75 Mn |
| Mar 31, 2020 | -2.18 Mn |
| Mar 31, 2020 | -2.18 Mn |
| Dec 31, 2019 | -1.14 Mn |
| Dec 31, 2019 | -1.14 Mn |
| Sep 30, 2019 | -1.71 Mn |
| Sep 30, 2019 | -1.71 Mn |
| Jun 30, 2019 | 66.75 Mn |
| Jun 30, 2019 | 66.75 Mn |
| Mar 31, 2019 | -1.04 Mn |
| Mar 31, 2019 | -1.04 Mn |
| Dec 31, 2018 | -285,000.00 |
| Dec 31, 2018 | -285,000.00 |
| Sep 30, 2018 | -224,000.00 |
| Sep 30, 2018 | -224,000.00 |
| Jun 30, 2018 | -334,000.00 |
| Jun 30, 2018 | -334,000.00 |
| Mar 31, 2018 | -8.09 Mn |
| Mar 31, 2018 | -8.09 Mn |
| Dec 31, 2017 | -24.59 Mn |
| Dec 31, 2017 | -24.59 Mn |
| Sep 30, 2017 | -27.57 Mn |
| Sep 30, 2017 | -27.57 Mn |
| Jun 30, 2017 | 4.91 Mn |
| Jun 30, 2017 | 4.91 Mn |
| Mar 31, 2017 | -13.14 Mn |
| Mar 31, 2017 | -13.14 Mn |
| Dec 31, 2016 | 698,000.00 |
| Dec 31, 2016 | 698,000.00 |
| Sep 30, 2016 | -6.58 Mn |
| Sep 30, 2016 | -6.58 Mn |
| Jun 30, 2016 | 833,000.00 |
| Jun 30, 2016 | 833,000.00 |
| Mar 31, 2016 | -3.11 Mn |
| Mar 31, 2016 | -3.11 Mn |
| Dec 31, 2015 | -18.54 Mn |
| Dec 31, 2015 | -18.54 Mn |
| Sep 30, 2015 | -3.73 Mn |
| Sep 30, 2015 | -3.73 Mn |
| Jun 30, 2015 | -2.91 Mn |
| Jun 30, 2015 | -2.91 Mn |
| Mar 31, 2015 | -11.05 Mn |
| Mar 31, 2015 | -11.05 Mn |
| Dec 31, 2014 | 889,000.00 |
| Dec 31, 2014 | 889,000.00 |
| Sep 30, 2014 | -68,000.00 |
| Sep 30, 2014 | -68,000.00 |
| Jun 30, 2014 | -4.15 Mn |
| Jun 30, 2014 | -4.15 Mn |
| Mar 31, 2014 | 1.19 Mn |
| Mar 31, 2014 | 1.19 Mn |
| Dec 31, 2013 | 37.67 Mn |
| Dec 31, 2013 | 37.67 Mn |
| Sep 30, 2013 | 1.28 Mn |
| Sep 30, 2013 | 1.28 Mn |
| Jun 30, 2013 | 545,929.00 |
| Jun 30, 2013 | 545,929.00 |
| Mar 31, 2013 | 1.14 Mn |
| Mar 31, 2013 | 1.14 Mn |
| Dec 31, 2012 | 238,123.00 |
| Dec 31, 2012 | 238,123.00 |
| Sep 30, 2012 | 5.99 Mn |
| Sep 30, 2012 | 5.99 Mn |
| Jun 30, 2012 | 136,004.00 |
| Jun 30, 2012 | 136,004.00 |
| Mar 31, 2012 | 243,673.00 |
| Mar 31, 2012 | 243,673.00 |
| Dec 31, 2011 | 4.95 Mn |
| Dec 31, 2011 | 4.95 Mn |
| Sep 30, 2011 | 386,878.00 |
| Sep 30, 2011 | 386,878.00 |
| Jun 30, 2011 | 2.90 Mn |
| Jun 30, 2011 | 2.90 Mn |
| Mar 31, 2011 | 1.90 Mn |
| Mar 31, 2011 | 1.90 Mn |